home.social

#cipla — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #cipla, aggregated by home.social.

  1. Cipla Reports Mixed Fiscal Signals Amidst India Focus

    Cipla's FY26 earnings calls reveal a strong focus on the Indian market. Find out what this means for investors and the company's future.

    #Cipla #IndianMarket #EarningsCall #PharmaNews #FY26

    newsletter.tf/cipla-fy26-earni

  2. Cipla's earnings calls from July 2025 to April 2026 show a repeated focus on the Indian market, with calls covering Q1 FY26, Q4 FY25, and Q4 FY26.

    #Cipla #IndianMarket #EarningsCall #PharmaNews #FY26
    newsletter.tf/cipla-fy26-earni

  3. 30 stocks to watch: Tata Motors, M&M, Brigade, HAL, Digilogic, Natco Pharma, Cipla

    misryoum.com/us/markets/30-sto

    Ola Electric has announced that its Roadster range now starts at just ₹79,999. This brings electric motorcycles directly at par with popular entry-segment ICE motorcycles. The company’s Roadster X portfolio comes in 2.5 kWh, 3.5 kWh and 4.5 kWh configurations,...

    #stocks #watch #Tata #Motors #Brigade #HAL #Digilogic #Natco #Pharma #Cipla #US_News_Hub #misryoum_com

  4. Stocks to Watch for March 4: ONGC, HPCL, Petronet, IGL, Cipla, Tata Motors CV, M&M and more

    misryoum.com/us/markets/stocks

    1 / 12Oil Sensitives | Oil sensitive stocks will continue to remain in focus during Wednesday's trading session as well with Brent Crude climbing back above the mark of $80 per barrel. Although ONGC and Oil India did not see...

    #Stocks #Watch #for #March #ONGC #HPCL #Petronet #IGL #Cipla #Tata #Motors #and #more #US_News_Hub #misryoum_com

  5. Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma

    New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
    #NewsBeep #News #Medication #anti-obesitymarket #cipla #diabetesdrug #EliLilly #Health #Mounjaro #PharmaTrac #Tirzepatide #UK #UnitedKingdom #Wegovy #Weight-lossdrug
    newsbeep.com/uk/250921/

  6. 📈#Cipla stock shrunk >2%

    Q3 numbers:

    ▪️India Sales: ₹2,859 cr (11.6%⬆️YoY)
    ▪️US Sales: ₹1,916 cr (19.8%⬆️YoY)
    ▪️EBITDA: ₹1,720 cr (24.9%⬆️YoY)

    📊View full Analysis on LinkedIn, link is in the thread

    Follow #goodluckcapital for #stockanalysis #StockMarketNews #stockadvice